Healthpeak Properties, Inc.
Analysis
Healthpeak is trading ownership for partnerships: senior housing went into a separately listed company, and Blackstone and Brookfield now own minority stakes in its medical buildings. Earnings now hang on whether four years of empty lab space finally fills.How much of that lab space is already leased but not yet paying rent?
- Lab occupancy finally turned up after four years of decline.
Occupancy has risen two quarters running and management expects to end 2026 above where it started. But the leases here are big, and rent only starts about a year after signing, so the earnings show up in 2027, not now.
- Outside investors now pay for the growth.
Blackstone and Brookfield bought into the outpatient buildings, with Healthpeak still managing and leasing them. The Brookfield stake alone raised $1 billion, and that cash funds new developments without selling shares or adding debt.How does the Brookfield recap price compare with the Blackstone one?
- Earnings are still falling even as the business improves.
Guidance for 2026 sits below what Healthpeak earned in 2025: lost lab rent hits now, refinancing $650 million of cheap debt costs more, and redevelopment cash goes out before any of that space pays rent.How much of Healthpeak's 2026 earnings drop is lost lab rent?
- Life science leasing recoveryLab demand is recovering and Healthpeak is winning more than its share of the leasing, so occupancy should rebuild rather than keep falling.
- Outpatient rent growthOutpatient medical has produced steady rent growth for years, and the largest institutional investors now want to own those buildings alongside Healthpeak.
- Senior housing separationThe senior housing IPO turned a portfolio the market ignored into a separately valued company, and Healthpeak kept most of the ownership.
- Lagging lab earningsLab earnings are still falling because leases lost last year only reach the income statement now, so profit per share is lower than a year ago.
- Negative free cash flowFree cash flow has turned negative as development and redevelopment spending outruns the cash the properties produce.
- Biotech tenant fundingLab tenants are mostly small biotechs that depend on raising capital, and the portfolio is concentrated in a handful of submarkets.
| Politician | Transaction | Amount | Traded | Filed |
|---|---|---|---|---|
Alan Armstrong Republican · Senate · OK | Purchase | ≥$1K | Mar 27 | Jul 21 |
Gilbert Ray Cisneros, Jr. Democratic · House · CA-31 | Sale | ≥$1K | Feb 10 | Mar 9 |
Gilbert Ray Cisneros, Jr. Democratic · House · CA-31 | Purchase | ≥$1K | Jan 9 | Feb 13 |
Lisa C. McClain Republican · House · MI-9 | Sale | ≥$1K | Aug 4 | Sep 12 |
Lisa C. McClain Republican · House · MI-9 | Purchase | ≥$1K | Jun 17 | Aug 13 |
Congressional trading data provided by QuiverQuant
How Healthpeak Properties turned $2.8B of revenue into $544.1M of operating income.
| Revenue | ||
|---|---|---|
| Outpatient Medical Buildings | $1.3B | |
| Lab | $860.0M | |
| Senior Housing | $604.0M | |
| Total revenue | $2.8B | |
| Gross profit | $634.5M | 22.5% |
| Operating income | $544.1M | 19.3% |